HUE060456T2 - Immunkompromittált alanyok oltása - Google Patents
Immunkompromittált alanyok oltásaInfo
- Publication number
- HUE060456T2 HUE060456T2 HUE15781436A HUE15781436A HUE060456T2 HU E060456 T2 HUE060456 T2 HU E060456T2 HU E15781436 A HUE15781436 A HU E15781436A HU E15781436 A HUE15781436 A HU E15781436A HU E060456 T2 HUE060456 T2 HU E060456T2
- Authority
- HU
- Hungary
- Prior art keywords
- vaccination
- immunocompromised subjects
- immunocompromised
- subjects
- Prior art date
Links
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462056019P | 2014-09-26 | 2014-09-26 | |
| EP14192174 | 2014-11-06 | ||
| US201562149351P | 2015-04-17 | 2015-04-17 | |
| PCT/IB2015/057388 WO2016046799A1 (en) | 2014-09-26 | 2015-09-25 | Vaccination of immunocompromised subjects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE060456T2 true HUE060456T2 (hu) | 2023-03-28 |
Family
ID=80116043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15781436A HUE060456T2 (hu) | 2014-09-26 | 2015-09-25 | Immunkompromittált alanyok oltása |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240342267A1 (hu) |
| EP (1) | EP4144369A1 (hu) |
| JP (1) | JP2022009403A (hu) |
| KR (1) | KR20230154072A (hu) |
| DK (1) | DK3197487T3 (hu) |
| ES (1) | ES2927797T3 (hu) |
| HU (1) | HUE060456T2 (hu) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007129290A1 (en) * | 2006-05-04 | 2007-11-15 | Prendergast Patrick T | Statins for the treatment of viral influenza infections |
| KR101625623B1 (ko) | 2009-12-03 | 2016-05-31 | 노파르티스 아게 | 백신 보조제 제조 중의 친수성 여과 |
| SG10201501611QA (en) | 2009-12-03 | 2015-04-29 | Novartis Ag | Circulation of components during microfluidization and/or homogenization emulsions |
| AU2010325751B2 (en) | 2009-12-03 | 2014-05-08 | Seqirus UK Limited | Arranging interaction and back pressure chambers for microfluidization |
| EP2742952A1 (en) * | 2012-12-17 | 2014-06-18 | Eurocine Vaccines AB | Influenza vaccine composition |
-
2015
- 2015-09-25 KR KR1020237034247A patent/KR20230154072A/ko not_active Application Discontinuation
- 2015-09-25 HU HUE15781436A patent/HUE060456T2/hu unknown
- 2015-09-25 ES ES15781436T patent/ES2927797T3/es active Active
- 2015-09-25 DK DK15781436.9T patent/DK3197487T3/da active
- 2015-09-25 EP EP22188224.4A patent/EP4144369A1/en not_active Withdrawn
-
2021
- 2021-10-22 JP JP2021172983A patent/JP2022009403A/ja active Pending
-
2023
- 2023-12-22 US US18/394,260 patent/US20240342267A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK3197487T3 (da) | 2022-09-05 |
| US20240342267A1 (en) | 2024-10-17 |
| EP4144369A1 (en) | 2023-03-08 |
| JP2022009403A (ja) | 2022-01-14 |
| KR20230154072A (ko) | 2023-11-07 |
| ES2927797T3 (es) | 2022-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201609265RA (en) | Characterizing states of subject | |
| ZA201700880B (en) | Polymorphs of selinexor | |
| GB201410971D0 (en) | Vaccine | |
| PL3185899T3 (pl) | Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd | |
| GB201515172D0 (en) | Measurement of respiratory function | |
| PL3190964T3 (pl) | Spirometr | |
| SG11201702844VA (en) | Photobioreactor | |
| GB2541615B (en) | Extraction of alkenes | |
| GB201619938D0 (en) | Observation cover of dermatoscope | |
| GB201416052D0 (en) | Configuration of user Interface | |
| GB201407090D0 (en) | Hairdryer | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| LT3188755T (lt) | Vakcina | |
| TWM490537U (en) | Structure of stand | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| GB201410118D0 (en) | Early diagnosis of leptospire | |
| GB201417214D0 (en) | Vaccine | |
| TWM489546U (en) | Improved structure of comb | |
| TWM490377U (en) | Improved structure of C clamp | |
| HUE060456T2 (hu) | Immunkompromittált alanyok oltása | |
| GB201406102D0 (en) | Novel speculum | |
| GB201406628D0 (en) | Vaccine | |
| TWM489230U (en) | Improved structure of pin set | |
| AP2015008263A0 (en) | Analysis of human immune status | |
| GB201412124D0 (en) | Rapid detection of medical conditions |